LU85631A1 - Oxazolidine - Google Patents
Oxazolidine Download PDFInfo
- Publication number
- LU85631A1 LU85631A1 LU85631A LU85631A LU85631A1 LU 85631 A1 LU85631 A1 LU 85631A1 LU 85631 A LU85631 A LU 85631A LU 85631 A LU85631 A LU 85631A LU 85631 A1 LU85631 A1 LU 85631A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- phenyl
- compounds according
- formula
- methyl
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH607083 | 1983-11-10 | ||
| CH6070/83A CH655931A5 (en) | 1983-11-10 | 1983-11-10 | Oxazolidines |
| CH449984 | 1984-09-20 | ||
| CH449984 | 1984-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU85631A1 true LU85631A1 (fr) | 1986-06-04 |
Family
ID=25695620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU85631A LU85631A1 (fr) | 1983-11-10 | 1984-11-07 | Oxazolidine |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US4743604A (fr) |
| AT (1) | AT387771B (fr) |
| AU (1) | AU576531B2 (fr) |
| BE (1) | BE900983A (fr) |
| CA (1) | CA1249992A (fr) |
| DE (1) | DE3438411A1 (fr) |
| DK (1) | DK520584A (fr) |
| ES (1) | ES8606863A1 (fr) |
| FI (1) | FI844152L (fr) |
| FR (1) | FR2554814B1 (fr) |
| GB (1) | GB2149405B (fr) |
| HU (1) | HU193465B (fr) |
| IL (1) | IL73427A (fr) |
| IT (1) | IT1177033B (fr) |
| LU (1) | LU85631A1 (fr) |
| MC (1) | MC1641A1 (fr) |
| NL (1) | NL8403308A (fr) |
| NO (1) | NO844501L (fr) |
| NZ (1) | NZ210105A (fr) |
| PH (1) | PH22462A (fr) |
| PT (1) | PT79485B (fr) |
| SE (1) | SE463099B (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU203330B (en) * | 1987-06-10 | 1991-07-29 | Pfizer | Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them |
| FI892341A (fi) * | 1988-06-10 | 1989-12-11 | Hoffmann La Roche | Propanolaminderivat. |
| US5321036A (en) * | 1993-02-10 | 1994-06-14 | Bristol-Myers Squibb Company | Thiazole and oxazole-based β3 adrenergic receptor agonists |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| SK111195A3 (en) * | 1994-09-13 | 1997-06-04 | Sandoz Technology Ltd | Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same |
| US7510849B2 (en) * | 2004-01-29 | 2009-03-31 | Glucolight Corporation | OCT based method for diagnosis and therapy |
| US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
| US7822452B2 (en) | 2004-08-11 | 2010-10-26 | Glt Acquisition Corp. | Method for data reduction and calibration of an OCT-based blood glucose monitor |
| US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
| US8571617B2 (en) | 2008-03-04 | 2013-10-29 | Glt Acquisition Corp. | Flowometry in optical coherence tomography for analyte level estimation |
| WO2014108449A1 (fr) | 2013-01-08 | 2014-07-17 | Atrogi Ab | Procédé de criblage, trousse, méthode de traitement et composé destinés à être utilisé dans une méthode de traitement |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA979912A (en) * | 1970-06-22 | 1975-12-16 | Frederic P. Hauck | Tetrahydronaphthyloxyaminopropanols and related compounds |
| GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
-
1984
- 1984-10-11 CA CA000465149A patent/CA1249992A/fr not_active Expired
- 1984-10-19 DE DE19843438411 patent/DE3438411A1/de not_active Withdrawn
- 1984-10-22 FI FI844152A patent/FI844152L/fi not_active Application Discontinuation
- 1984-10-25 IT IT23307/84A patent/IT1177033B/it active
- 1984-10-31 NL NL8403308A patent/NL8403308A/nl not_active Application Discontinuation
- 1984-11-01 US US06/667,186 patent/US4743604A/en not_active Expired - Fee Related
- 1984-11-01 DK DK520584A patent/DK520584A/da not_active Application Discontinuation
- 1984-11-05 NZ NZ210105A patent/NZ210105A/xx unknown
- 1984-11-05 IL IL73427A patent/IL73427A/xx unknown
- 1984-11-06 MC MC841735A patent/MC1641A1/fr unknown
- 1984-11-06 BE BE0/213953A patent/BE900983A/fr not_active IP Right Cessation
- 1984-11-07 LU LU85631A patent/LU85631A1/fr unknown
- 1984-11-08 FR FR8417009A patent/FR2554814B1/fr not_active Expired
- 1984-11-08 ES ES537487A patent/ES8606863A1/es not_active Expired
- 1984-11-09 PH PH31427A patent/PH22462A/en unknown
- 1984-11-09 AU AU35275/84A patent/AU576531B2/en not_active Ceased
- 1984-11-09 GB GB08428335A patent/GB2149405B/en not_active Expired
- 1984-11-09 AT AT0355384A patent/AT387771B/de not_active IP Right Cessation
- 1984-11-09 PT PT79485A patent/PT79485B/pt unknown
- 1984-11-09 NO NO844501A patent/NO844501L/no unknown
- 1984-11-09 SE SE8405632A patent/SE463099B/sv not_active IP Right Cessation
- 1984-11-09 HU HU844174A patent/HU193465B/hu unknown
-
1988
- 1988-02-05 US US07/152,522 patent/US4871755A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0101069B1 (fr) | Phénéthanolamines | |
| EP0140243B1 (fr) | Phénoxypropanolamines | |
| LU85631A1 (fr) | Oxazolidine | |
| EP0254856B1 (fr) | Dérivés de pyridinéthanolamines | |
| EP0400011B1 (fr) | Phenylethanolamines | |
| EP0094595B1 (fr) | Dérivés de l'aziridine et de la phényléthanolamine | |
| DE2332837A1 (de) | Amine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| EP0198412B1 (fr) | Dérivés de la phénéthanolamine | |
| AU622907B2 (en) | Propanolamine derivatives | |
| DE2633245A1 (de) | 4-hydroxy-1,3-benzoldimethanolverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| EP0013749A1 (fr) | Hexahydro-1,4-oxazépines, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| DE2404328A1 (de) | Verfahren zur herstellung von alpha(l-aralkylaminoalkyl)-aralkoxybenzylalkoholen | |
| AU617353B2 (en) | Pyridylethanolamines | |
| DE2644972A1 (de) | Thiaprostaglandine | |
| DE1518334C3 (de) | Substituierte Benzylamme und ihre Salze sowie Verfahren zu ihrer Herstellung | |
| CH655931A5 (en) | Oxazolidines | |
| DE2743493A1 (de) | Amine, verfahren zu deren herstellung und sie enthaltende arzneimittel | |
| EP0386603A2 (fr) | Bisphénéthanolamine | |
| KR820002065B1 (ko) | 펜에탄올 아민류의 제조방법 | |
| AT353272B (de) | Verfahren zur herstellung von neuen piperidin- derivaten sowie von deren salzen und optisch aktiven formen | |
| AT371101B (de) | Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon | |
| DE3025325A1 (de) | Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten | |
| DE1768366B2 (de) | 3-hydroxy-alpha-(1-aminoaethyl)benzylalkohol-derivate und diese enthaltende arzneimittel | |
| DE3000441A1 (de) | Anilinderivate,,diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung | |
| DE2411640A1 (de) | Verfahren zur herstellung von neuen polycyclischen aminen |